prognosis
Last reviewed 01/2018
Overall:
- stage I - 95% survival at 5 years
- stage IV - 20% survival at 5 years
Favourable prognosis associated with:
- age less than 1 year at diagnosis:
- 50% 5 year survival for those diagnosed at 1 year
- 20% 5 year survival for those diagnosed at 10 years
- stage I and II disease
- cervical, pelvic, mediastinal, orbital primary tumours
- normal neurone-specific enolase and ferritin at diagnosis
- high vanylmandelic to homovanillic acid ratio
- less than 3 copies of N-myc oncogene
- low telomerase activity
- stage IVS has a prognosis as good as stage II